drugset / Trial / NCT02956616

Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay

NCT02956616

Phase 2 Completed 118 enrolled Montefiore Medical Center
RandomizedParallel-groupSingle-blindSupportive care

Summary

To determine whether women randomized to an enhanced recovery program will have improved postoperative outcomes including improved breastfeeding initiation and continuation, reduction in hospital length of stay without compromising patient satisfaction in comparison to standard postoperative recovery interventions.

Timeline

Start
2017-09-01
Primary completion
2018-06-15
Completion
2018-06-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Ketorolac Other / unclassified 15 mg

Indications

No indication recorded.